Semaslim Injection 1.7 mg/0.75 ml contains Semaglutide, a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist used in the management of type 2 diabetes mellitus and, in selected patients, for chronic weight management. It helps regulate blood glucose levels, reduces appetite, and supports sustained weight reduction when combined with proper diet and exercise.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

• Active Ingredient: Semaglutide 1.7 mg per 0.75 ml

Indications

Semaslim Injection is indicated for:

• Type 2 diabetes mellitus (as an adjunct to diet and exercise)
• Weight management in overweight or obese adults (as prescribed by a physician)
• Reduction of cardiovascular risk in selected high-risk diabetic patients

Mechanism of Action

Semaglutide mimics the natural GLP-1 hormone and works by:

• Enhancing insulin secretion in a glucose-dependent manner
• Reducing glucagon release
• Slowing gastric emptying
• Decreasing appetite and food intake

These combined effects help improve glycemic control and promote weight loss.

Dosage and Administration

• Administered as a subcutaneous injection once weekly or as directed by a physician
• The 1.7 mg dose is typically used as an intermediate or higher titration step in patients who tolerate lower doses
• Inject into abdomen, thigh, or upper arm
• Rotate injection sites to avoid irritation
• Follow proper training for self-administration

Benefits

• Helps improve long-term blood sugar control
• Supports significant weight reduction in appropriate patients
• Reduces appetite and calorie intake
• May lower cardiovascular risk in high-risk individuals
• Convenient once-weekly dosing

Possible Side Effects

Common side effects may include:

• Nausea
• Vomiting
• Diarrhea or constipation
• Abdominal discomfort
• Reduced appetite

Serious side effects:

• Pancreatitis
• Gallbladder disease
• Severe dehydration
• Hypoglycemia (especially with insulin or sulfonylureas)

Seek immediate medical attention if severe symptoms occur.

Precautions and Warnings

• Not indicated for type 1 diabetes mellitus
• Use with caution in patients with a history of pancreatitis
• Not recommended during pregnancy or breastfeeding unless advised by a physician
• Regular monitoring of blood glucose is recommended
• May delay gastric emptying and affect absorption of oral medications

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Drug Interactions

Semaslim Injection may interact with:

• Insulin and other antidiabetic medications
• Oral drugs affected by delayed gastric emptying
• Other weight management therapies

Always inform your healthcare provider about all medicines being taken.

Storage

• Store in a refrigerator at 2°C to 8°C
• Do not freeze
• Protect from light
• Keep out of reach of children.